Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma - Feasibility of initial clinical translation

Radiology

Volumn 246, Issue 3, 2008, Pages 964-971

  Larson, Andrew C ^a,b   Wang, Dingxin ^a,b   Atassi, Bassel ^a   Sato, Kent T ^a   Ryu, Robert K ^a   Lewandowski, Robert J ^a   Nemcek Jr , Albert A ^a   Mulcahy, Mary F ^a   Kulik, Laura M ^a   Miller, Frank H ^a   Salem, Riad ^a   Omary, Reed A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTERY PERFUSION; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; FEASIBILITY STUDY; FEMALE; HUMAN; HYPOTHESIS; LIVER; LIVER CELL CARCINOMA; LIVER PARENCHYMA; LIVER PERFUSION; MALE; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; INTERVENTIONAL RADIOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CIRCULATION; LIVER TUMOR; MAGNETIC RESONANCE ANGIOGRAPHY; METHODOLOGY; TREATMENT OUTCOME;

CISPLATIN; CONTRAST MEDIUM; DOXORUBICIN; ETHIODIZED OIL; IOHEXOL; MITOMYCIN;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; CONTRAST MEDIA; DOXORUBICIN; ETHIODIZED OIL; FEASIBILITY STUDIES; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; IOHEXOL; LIVER CIRCULATION; LIVER NEOPLASMS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MITOMYCIN; PROSPECTIVE STUDIES; RADIOGRAPHY, INTERVENTIONAL; TREATMENT OUTCOME;

EID: 40949150626     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2463070725     Document Type: Article

References (24)

1. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-1739.
2. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-1171.
3. Soo CS, Chuang VP, Wallace S, Charnsangavej C, Carrasco H. Treatment of hepatic neoplasm through extrahepatic collaterals. Radiology 1983;147:45-49.
4. Charnsangavej C, Chuang VP, Wallace S, Soo CS, Bowers T. Angiographic classification of hepatic arterial collaterals. Radiology 1982;144:485-494.
5. Rhee TK, Larson AC, Prasad PV, et al. Feasibility of blood oxygenation level-dependent MR imaging to monitor hepatic transcatheter arterial embolization in rabbits. J Vasc Interv Radiol 2005;16:1523-1528.
6. Wilson MW, Kerlan RK Jr, Fidelman NA, et al. Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/conventional angiography suite - initial experience with four patients. Radiology 2004;230:287-293.
7. Wang D, Bangash A, Rhee TK, et al. Liver tumors: monitoring embolization in rabbits with VX2 tumors - transcatheter intraarterial first-pass perfusion MR imaging. Radiology 2007;245:130-139.
8. Brown DB, Cardella JF, Sacks D, et al. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 2006;17:225-232.
9. Georgiades CS, Hong K, D'Angelo M, Geschwind JF. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 2005;16:1653-1659.
10. Bruix J, Sherman M, Llovet JM, et al; for the European Association for the Study of the Liver. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421-430.
11. Materne R, Smith AM, Peeters F, et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002;47:135-142.
12. Pandharipande PV, Krinsky GA, Rusinek H, Lee VS. Perfusion imaging of the liver: current challenges and future goals. Radiology 2005;234:661-673.
13. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985;312:932-936.
14. Guo WJ, Li J, Chen Z, et al. Transient increased expression of VEGF and MMP-1 in a rat liver tumor model after hepatic arterial occlusion. Hepatogastroenterology 2004;51:381-386.
15. Rhee TK, Young JY, Larson AC, et al. Effect of transcatheter arterial embolization on levels of hypoxia inducible factor-1 alpha in rabbit VX2 liver tumors. J Vasc Interv Radiol 2007;18:639-645.
16. Scharf J, Zapletal C, Hess T, et al. Assessment of hepatic perfusion in pigs by pharmacokinetic analysis of dynamic MR images. J Magn Reson Imaging 1999;9:568-572.
17. Jackson A, Haroon H, Zhu XP, Li KL, Thacker NA, Jayson G. Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model. NMR Biomed 2002;15:164-173.
18. Vogl TJ, Balzer JO, Mack MG, Bett G, Oppelt A. Hybrid MR interventional imaging system: combined MR and angiography suites with single interactive table - feasibility study in vascular liver tumor procedures. Eur Radiol 2002;12:1394-1400.
19. Larson AC, Rhee TK, Deng J, et al. Comparison between intravenous and intraarterial contrast injections for dynamic 3D MRI of liver tumors in the VX2 rabbit model. J Magn Reson Imaging 2006;24:242-247.
20. Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K. Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma. Cancer 2001;91:1342-1348.
21. Tanigawa N, Komemushi A, Kojima H, Kariya S, Sawada S. Three-dimensional angiography using rotational digital subtraction angiography: usefulness in transarterial embolization of hepatic tumors. Acta Radiol 2004;45:602-607.
22. Virmani S, Ryu RK, Sato KT, et al. Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. J Vasc Interv Radiol 2007;18:1305-1309.
23. De Santis M, Alborino S, Tartoni PL, Torricelli P, Casolo A, Romagnoli R. Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization. Eur Radiol 1997;7:10-16.
24. Michels NA. Collateral arterial pathways to the liver after ligation of the hepatic artery and removal of the celiac axis. Cancer 1953;6:708-724.